Zalicus Inc (ZLCS)

[wildbullus]

$ZLCS Zalicus Inc. and Hydra Biosciences, Inc announced that they have entered into a collaboration to advance development of Zalicus’ preclinical ion channel modulator product candidates for the treatment of pain. This collaboration brings together the Zalicus portfolio of, preclinical ion channel product candidates, representing multiple calcium and sodium channel modulators, with Hydra’s in ion channel discovery and preclinical drug development. The goal of the collaboration is to advance ion channel drug candidates into clinical development for the treatment of pain.